UK BMT Pharmacists’ Group has recently updated its training passport

The UK BMT Pharmacists’ Group has recently updated its training passport that is designed to support pharmacists working in the area of adult haematopoietic stem cell transplantation (HSCT). It is based around the FACT-JACIE International Standards for Haematopoietic Cellular Therapy (currently 7th edition, 2018) which require that all designated pharmacists providing a service to HSCT patients must demonstrate the minimum JACIE requirements for continuing accreditation. We hope that the passport will continue to provide a useful core template that individual centres can build their own training programmes around. The passport also contains a set of assessment questions – for a copy of the model answers please email [email protected].

To access the document click here: https://www.bopa.org.uk/bmt-training-passport/

Latest News

By BOPA Research Committee on 25th April 2024

Survey: Pharmacogenomic Panel Testing in Cancer: UK Oncology Professionals

Please consider completing our BOPA member survey on the use of pharmacogenomic panel testing in people with solid tumours. Survey information I’m a pharmacist and pre-doctoral research fellow researching the…

Read article
By BOPA Research committee on 25th April 2024

NIHR Associate Principal Investigator (PI) Scheme is continuing to host Research Learning Lectures

The NIHR Associate Principal Investigator (PI) Scheme is continuing to host the Research Learning Lectures; a series of lectures for anyone in Health and Social Care interested in learning more about research.…

Read article
By BOPA on 16th April 2024

Abstract Submission for #BOPA2024 is NOW OPEN

Abstract Submission for the 27th Annual BOPA Conference in 2024 is now OPEN   Delegates are invited to present results of their clinical and technical work as a poster with…

Read article
By BOPA Research Subcommittee on 15th April 2024

Survey: Service Evaluation on Carboplatin Variation in UK

We invite members to complete this service evaluation to understand national variations in carboplatin dosing for adult patients receiving SACTs. We are looking at whether we can standardise carboplatin protocols…

Read article